Products for Research Use Only
RegisterLogin

Alogliptin (Benzoate)

CAT: 0804-HY-A0023-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-A0023-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Alogliptin Benzoate (SYR-322) is a potent, selective and orally active inhibitor of DPP-4 with an IC50 of [1][2][3].
CAS Number
850649-62-6
Product Name Alternative
SYR 322
UNSPSC
12352005
Hazard Statement
H302, H312, H332
Target
Dipeptidyl Peptidase; Ferroptosis
Type
Reference compound
Related Pathways
Apoptosis; Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease; Inflammation/Immunology; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/alogliptin-benzoate.html
Purity
99.98
Solubility
DMSO : 25 mg/mL (ultrasonic; warming; heat to 60°C) |H2O : 14.29 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(C=C(N1C[C@H](N)CCC1)N(C2=O)CC3=C(C#N)C=CC=C3)N2C.O=C(O)C4=CC=CC=C4
Molecular Formula
C25H27N5O4
Molecular Weight
461.51
Precautions
H302, H312, H332
References & Citations
[1]Feng J, et, al. Discovery of alogliptin: a potent, selective, bioavailable, and efficacious inhibitor of dipeptidyl peptidase IV. J Med Chem. 2007 May 17;50 (10) :2297-300.|[2]Ta NN, et, al. DPP-4 (CD26) inhibitor alogliptin inhibits TLR4-mediated ERK activation and ERK-dependent MMP-1 expression by U937 histiocytes. Atherosclerosis. 2010 Dec;213 (2) :429-35.|[3]Hao FL, et, al. The neurovascular protective effect of alogliptin in murine MCAO model and brain endothelial cells. Biomed Pharmacother. 2019 Jan;109:181-187.|[4]Asakawa T, et, al. A novel dipeptidyl peptidase-4 inhibitor, alogliptin (SYR-322), is effective in diabetic rats with sulfonylurea-induced secondary failure. Life Sci. 2009 Jul 17;85 (3-4) :122-6.|[5]Moritoh Y, et al. The dipeptidyl peptidase-4 inhibitor alogliptin in combination with pioglitazone improves glycemic control, lipid profiles, and increases pancreatic insulin content in ob/ob mice. Eur J Pharmacol. 2009 Jan 14;602 (2-3) :448-54.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
Launched
Isoform
DPP-4
Citation 01
Biochem Biophys Res Commun. 2019 Apr 2;511 (2) :387-393. |Biol Chem. 2023 Jan 12;404 (6) :633-643.|Chromatography. 2015,36 (1) :19-24.|Research Square Preprint. 2025 Jan 08.|Sci Rep. 2019 Dec 2;9 (1) :18094.|Sci Signal. 2023 Jan 17;16 (768) :eabh1083.

Related Products

CatalogName
HY-A0023AS2Alogliptin-13C, d3 (benzoate)
HY-A0023A-01Alogliptin
HY-A0023AS1-01Alogliptin-d3
HY-A0023AR-01Alogliptin (Standard)
HY-A0023AS-01Alogliptin-13C, d3
HY-I0293SAlogliptin impurity 7-d3
HY-W101585-01Isoamyl benzoate
HY-W015761-01Ammonium benzoate
HY-N8579Eugenyl benzoate
HY-N10863-01Aurantiamide benzoate

Alternative Products

CatalogName
A3156-10Alogliptin Benzoate
A13311-50Alogliptin Benzoate 50mg
A13311-10Alogliptin Benzoate 10mg
A13311-100Alogliptin Benzoate 100mg
A13311-25Alogliptin Benzoate 25mg

Popular Products